直腸癌合并疑似分泌多巴胺的嗜鉻細胞瘤一例_West China Medical Journal

Authors：

何雪梅 ,  王儒蓉

四川大學華西醫院麻醉科（成都 610041）;

Corresponding?author：

王儒蓉, Email: wanrurong@scu.edu.cn

Keywords：

多巴胺; 腎上腺增粗; 嗜鉻細胞瘤; 圍手術期管理

DOI：

10.7507/1002-0179.202012226

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 何雪梅, 王儒蓉. 直腸癌合并疑似分泌多巴胺的嗜鉻細胞瘤一例. West China Medical Journal, 2021, 36(5): 698-700. doi: 10.7507/1002-0179.202012226 Copy

1.	Aygun N, Uludag M. Pheochromocytoma and paraganglioma: from epidemiology to clinical findings. Sisli Etfal Hastan Tip Bul, 2020, 54(2): 159-168.
2.	Lenders JW, Eisenhofer G, Mannelli M, et al. Phaeochromocytoma. Lancet, 2005, 366(9486): 665-675.
3.	中華醫學會內分泌學分會. 嗜鉻細胞瘤和副神經節瘤診斷治療專家共識(2020 版). 中華內分泌代謝雜志, 2020, 36(9): 737-750.
4.	Falhammar H, Stenman A, Calissendorff J, et al. Presentation, treatment, histology, and outcomes in adrenal medullary hyperplasia compared with pheochromocytoma. J Endocr Soc, 2019, 3(8): 1518-1530.
5.	Poirier é, Thauvette D, Hogue JC. Management of exclusively dopamine-secreting abdominal pheochromocytomas. J Am Coll Surg, 2013, 216(2): 340-346.
6.	Yi JW, Oh EM, Lee KE, et al. An exclusively dopamine secreting paraganglioma in the retroperitoneum: a first clinical case in Korea. J Korean Surg Soc, 2012, 82(6): 389-393.
7.	Matsuda Y, Kimura N, Yoshimoto T, et al. Dopamine-secreting paraganglioma in the retroperitoneum. Endocr Pathol, 2017, 28(1): 36-40.
8.	Jing J, Yu M, Jiang B. An adrenal incidentaloma diagnosed as dopamine-secreting pheochromocytoma: a case report. J Natl Med Assoc, 2021, 113(1): 46-50.
9.	Patin F, Crinière L, Francia T, et al. Low specificity of urinary 3-methoxytyramine in screening of dopamine-secreting pheochromocytomas and paragangliomas. Clin Biochem, 2016, 49(15): 1205-1208.
10.	Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2014, 99(6): 1915-1942.
11.	Kenny L, Rizzo V, Trevis J, et al. The unexpected diagnosis of phaeochromocytoma in the anaesthetic room. Ann Card Anaesth, 2018, 21(3): 307-310.
12.	Fox WC, Read M, Moon RE, et al. An undiagnosed paraganglioma in a 58-year-old female who underwent tumor resection. Case Rep Anesthesiol, 2017, 2017: 5796409.
13.	汪一, 張羽冠, 徐宵寒, 等. 成人嗜鉻細胞瘤術中麻醉研究進展. 中華醫學雜志, 2019, 99(21): 1676-1680.
14.	Dubois LA, Gray DK. Dopamine-secreting pheochromocytomas: in search of a syndrome. World J Surg, 2005, 29(7): 909-913.
15.	Tam V, Ng KF, Fung LM, et al. The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient with dopamine-secreting paraganglioma. Ann Clin Biochem, 2005, 42(Pt 1): 73-77.

1. Aygun N, Uludag M. Pheochromocytoma and paraganglioma: from epidemiology to clinical findings. Sisli Etfal Hastan Tip Bul, 2020, 54(2): 159-168.
2. Lenders JW, Eisenhofer G, Mannelli M, et al. Phaeochromocytoma. Lancet, 2005, 366(9486): 665-675.
3. 中華醫學會內分泌學分會. 嗜鉻細胞瘤和副神經節瘤診斷治療專家共識(2020 版). 中華內分泌代謝雜志, 2020, 36(9): 737-750.
4. Falhammar H, Stenman A, Calissendorff J, et al. Presentation, treatment, histology, and outcomes in adrenal medullary hyperplasia compared with pheochromocytoma. J Endocr Soc, 2019, 3(8): 1518-1530.
5. Poirier é, Thauvette D, Hogue JC. Management of exclusively dopamine-secreting abdominal pheochromocytomas. J Am Coll Surg, 2013, 216(2): 340-346.
6. Yi JW, Oh EM, Lee KE, et al. An exclusively dopamine secreting paraganglioma in the retroperitoneum: a first clinical case in Korea. J Korean Surg Soc, 2012, 82(6): 389-393.
7. Matsuda Y, Kimura N, Yoshimoto T, et al. Dopamine-secreting paraganglioma in the retroperitoneum. Endocr Pathol, 2017, 28(1): 36-40.
8. Jing J, Yu M, Jiang B. An adrenal incidentaloma diagnosed as dopamine-secreting pheochromocytoma: a case report. J Natl Med Assoc, 2021, 113(1): 46-50.
9. Patin F, Crinière L, Francia T, et al. Low specificity of urinary 3-methoxytyramine in screening of dopamine-secreting pheochromocytomas and paragangliomas. Clin Biochem, 2016, 49(15): 1205-1208.
10. Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2014, 99(6): 1915-1942.
11. Kenny L, Rizzo V, Trevis J, et al. The unexpected diagnosis of phaeochromocytoma in the anaesthetic room. Ann Card Anaesth, 2018, 21(3): 307-310.
12. Fox WC, Read M, Moon RE, et al. An undiagnosed paraganglioma in a 58-year-old female who underwent tumor resection. Case Rep Anesthesiol, 2017, 2017: 5796409.
13. 汪一, 張羽冠, 徐宵寒, 等. 成人嗜鉻細胞瘤術中麻醉研究進展. 中華醫學雜志, 2019, 99(21): 1676-1680.
14. Dubois LA, Gray DK. Dopamine-secreting pheochromocytomas: in search of a syndrome. World J Surg, 2005, 29(7): 909-913.
15. Tam V, Ng KF, Fung LM, et al. The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient with dopamine-secreting paraganglioma. Ann Clin Biochem, 2005, 42(Pt 1): 73-77.

Previous Article
地中海貧血并發慢性下肢潰瘍兩例

West China Medical Journal

直腸癌合并疑似分泌多巴胺的嗜鉻細胞瘤一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content